is manjaro a glp-1 drug Manjaro* GOOD or BAD Mounjaro (tirzepatide) once-weekly subcutaneous injectable medication that functions as a dual agonist of glucagon like peptide-1 (GLP-1) and glucose dependent insulinotropic polypeptide (GIP) receptors. It is Tirzepatide (Mounjaro)
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




























